TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T52067	Solute carrier family 15 member 2	D00HWO	Cyclacillin	Approved	19003	C15H23N3O4S	341.4	CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)C3(CCCCC3)N)C(=O)O)C	IC50 = 610000 nM	Non binder
T52067	Solute carrier family 15 member 2	D01PLN	Cefalotin	Approved	6024	C16H16N2O6S2	396.4	CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)CC3=CC=CS3)SC1)C(=O)O	Ki = 8300000 nM	Non binder
T52067	Solute carrier family 15 member 2	D04KTZ	Cloxacillin	Approved	6098	C19H18ClN3O5S	435.9	CC1=C(C(=NO1)C2=CC=CC=C2Cl)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O	Ki = 950000 nM	Non binder
T52067	Solute carrier family 15 member 2	D05UBX	Cefmetazole	Approved	42008	C15H17N7O5S3	471.5	CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@](C3=O)(NC(=O)CSCC#N)OC)SC2)C(=O)O	Ki = 4265795.19 nM	Non binder
T52067	Solute carrier family 15 member 2	D06OVY	Cefixime	Approved	5362065	C16H15N5O7S2	453.5	C=CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\\OCC(=O)O)/C3=CSC(=N3)N)SC1)C(=O)O	Ki = 2570395.78 nM	Non binder
T52067	Solute carrier family 15 member 2	D06YHL	Cefamandole	Approved	456255	C18H18N6O5S2	462.5	CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)[C@@H](C4=CC=CC=C4)O)SC2)C(=O)O	Ki = 2800000 nM	Non binder
T52067	Solute carrier family 15 member 2	D0A1CB	Cefepime	Approved	5479537	C19H24N6O5S2	480.6	C[N+]1(CCCC1)CC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\\OC)/C4=CSC(=N4)N)SC2)C(=O)[O-]	Ki = 10964781.96 nM	Non binder
T52067	Solute carrier family 15 member 2	D0F6EO	Amoxicillin	Approved	33613	C16H19N3O5S	365.4	CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=C(C=C3)O)N)C(=O)O)C	Ki = 426579.52 nM	Non binder
T52067	Solute carrier family 15 member 2	D0MB8I	Oxacillin	Approved	6196	C19H19N3O5S	401.4	CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O	Ki = 3300000 nM	Non binder
T52067	Solute carrier family 15 member 2	D0R2KJ	Dicloxacillin	Approved	18381	C19H17Cl2N3O5S	470.3	CC1=C(C(=NO1)C2=C(C=CC=C2Cl)Cl)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O	Ki = 416869.38 nM	Non binder
T52067	Solute carrier family 15 member 2	D0W6CA	Cefpodoxime	Approved	6335986	C15H17N5O6S2	427.5	COCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\\OC)/C3=CSC(=N3)N)SC1)C(=O)O	Ki = 30902954.33 nM	Non binder
T52067	Solute carrier family 15 member 2	D0YA9Z	Ampicillin	Approved	6249	C16H19N3O4S	349.4	CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)C(=O)O)C	Ki = 1288249.55 nM	Non binder
T52067	Solute carrier family 15 member 2	D00QAR	Benzylpenicillin	Phase 3	5904	C16H18N2O4S	334.4	CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C	Ki = 10964781.96 nM	Non binder
T52067	Solute carrier family 15 member 2	D0F8IO	Cephaloridine	Withdrawn from market	5773	C19H17N3O4S2	415.5	C1C(=C(N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CS3)C(=O)[O-])C[N+]4=CC=CC=C4	Ki = 8500000 nM	Non binder
T52067	Solute carrier family 15 member 2	B7BPQ2	Cefotaxime	Investigative	5742673	C16H17N5O7S2	455.5	CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\\OC)/C3=CSC(=N3)N)SC1)C(=O)O	Ki = 19952623.15 nM	Non binder
T52067	Solute carrier family 15 member 2	B7L8SG	Cefodizime	Investigative	5361871	C20H20N6O7S4	584.7	CC1=C(SC(=N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\\OC)/C4=CSC(=N4)N)SC2)C(=O)O)CC(=O)O	Ki = 8912509.38 nM	Non binder
T52067	Solute carrier family 15 member 2	B8DY3N	H-Pro-gly-gly-OH	Investigative	97050	C9H15N3O4	229.23	C1C[C@H](NC1)C(=O)NCC(=O)NCC(=O)O	Ki = 10964781.96 nM	Non binder
T52067	Solute carrier family 15 member 2	B9OK4Y	(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-Amino-3-phenylpropanoyl]amino]propanoyl]amino]-3-hydroxybutanoyl]amino]propanoyl]amino]propanoic acid	Investigative	56668511	C22H33N5O7	479.5	C[C@H]([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC1=CC=CC=C1)N)O	Ki = 239883.29 nM	Non binder
T52067	Solute carrier family 15 member 2	BA0KZ4	Cephapirin sodium	Investigative	23675312	C17H16N3NaO6S2	445.4	CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)CSC3=CC=NC=C3)SC1)C(=O)[O-].[Na+]	Ki = 11100000 nM	Non binder
T52067	Solute carrier family 15 member 2	BG7T1Q	Glycyl-l-histidyl-l-lysine	Investigative	73587	C14H24N6O4	340.38	C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)CN	Ki = 3090295.43 nM	Non binder
T52067	Solute carrier family 15 member 2	BH3SW7	Cefuroxime	Investigative	5479529	C16H16N4O8S	424.4	CO/N=C(/C1=CC=CO1)\\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)O	Ki = 12589254.12 nM	Non binder
T52067	Solute carrier family 15 member 2	BJD4B1	Metampicillin	Investigative	6713928	C17H19N3O4S	361.4	CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N=C)C(=O)O)C	Ki = 724435.96 nM	Non binder
T52067	Solute carrier family 15 member 2	BL0E4J	(2S)-6-Amino-2-[[(2S)-3-phenyl-2-[[(2S)-pyrrolidine-2-carbonyl]amino]propanoyl]amino]hexanoic Acid	Investigative	7408741	C20H30N4O4	390.5	C1C[C@H](NC1)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CCCCN)C(=O)O	Ki = 891250.94 nM	Non binder
T52067	Solute carrier family 15 member 2	BNA5E3	(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-Aminopropanoyl]amino]-3-hydroxybutanoyl]amino]propanoyl]amino]propanoic acid	Investigative	56665053	C13H24N4O6	332.35	C[C@H]([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](C)N)O	Ki = 549540.87 nM	Non binder
T52067	Solute carrier family 15 member 2	BOQ49J	Alanyl-D-alanine	Investigative	96796	C6H12N2O3	160.17	C[C@@H](C(=O)N[C@H](C)C(=O)O)N	Ki = 269153.48 nM	Non binder
T52067	Solute carrier family 15 member 2	BQ95TO	Pro-Asp	Investigative	7079450	C9H14N2O5	230.22	C1C[C@H](NC1)C(=O)N[C@@H](CC(=O)O)C(=O)O	Ki = 2089296.13 nM	Non binder
T52067	Solute carrier family 15 member 2	BZI9Q2	Prolylglutamic acid	Investigative	194260	C10H16N2O5	244.24	C1C[C@H](NC1)C(=O)N[C@@H](CCC(=O)O)C(=O)O	Ki = 2570395.78 nM	Non binder
T52067	Solute carrier family 15 member 2	D0A1PW	Laevulinic Acid	Investigative	11579	C5H8O3	116.11	CC(=O)CCC(=O)O	Ki = 229086.77 nM	Non binder